Dr Reddys Laboratories RDY
NYSE RDY
$12.85 +0.34 (+2.68%)
As of: Sep 29, 2026 · 3:59 PM EDT

Dr Reddys Laboratories (RDY) EPS (Diluted) (2009 - 2026)

Updated

Dr Reddys Laboratories' EPS (Diluted) was $0.06 in the quarter ended Jun 30, 2026, down 71.7% from $0.20 a year earlier and down 99.9% from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) EPS (Diluted) (2009 - 2026) Analysis & Trends

On a trailing twelve-month basis, Dr Reddys Laboratories' EPS (Diluted) was $204.83 through Jun 30, 2026, up 87.5% year-over-year; for the year ended Mar 31, 2026, it came in at $0.55, down 99.9% from the prior year.

  • EPS (Diluted) shows a five-year compound annual growth rate of 6.8% (years ended Mar 2021 to Mar 2026).
  • In earlier years, EPS (Diluted) was $404.48 in the year ended Mar 31, 2025, $0.81 in the year ended Mar 31, 2024 (+19.5%), $0.68 in the year ended Mar 31, 2023 (+41.9%) and $0.48 in the year ended Mar 31, 2022 (+21.1%).
  • The figure for the quarter ended Jun 30, 2026 marks the lowest quarterly EPS (Diluted) since the quarter ended Mar 31, 2022.
  • Compared with a year earlier, EPS (Diluted) was higher in two of the last six quarters, with an average decline of 10.7%.
  • The best year-over-year quarter for EPS (Diluted) over five years was the quarter ended Mar 31, 2023 (growth of 645.3%); the worst was the quarter ended Mar 31, 2022 (a decline of 74.0%).
  • Per Business Quant data, RDY's EPS (Diluted) in the three quarters before the quarter ended Jun 30, 2026 was $96.26 (quarter ended Mar 31, 2026), $108.16 (quarter ended Dec 31, 2025) and $0.24 (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 2.27
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 2.04
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -0.54
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 1.67
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 1.85
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 4.37
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -8.44
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -0.04
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 4.31
10 Dr Reddys Laboratories 10.44 Bn 9.62 Bn 396.53 Mn 0.06
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 0.06
Mar 31, 2026 96.26
Dec 31, 2025 108.16
Sep 30, 2025 0.24
Jun 30, 2025 0.20
Mar 31, 2025 108.50
Dec 31, 2024 0.27
Sep 30, 2024 0.25
Jun 30, 2024 0.20
Mar 31, 2024 0.22
Dec 31, 2023 0.25
Sep 30, 2023 0.22
Jun 30, 2023 0.26
Mar 31, 2023 0.18
Dec 31, 2022 0.24
Sep 30, 2022 0.24
Jun 30, 2022 0.19
Mar 31, 2022 0.02
Dec 31, 2021 0.15
Sep 30, 2021 0.20
API Access

Dr Reddys Laboratories EPS (Diluted) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-diluted&ticker=RDY&period=max&api_key=YOUR_API_KEY